"
Template:SupbiotechparisEn
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 59: | Line 59: | ||
<div id="menu"> | <div id="menu"> | ||
<div style="margin-bottom: 40px; margin-top: 320px; background: transparent;"> | <div style="margin-bottom: 40px; margin-top: 320px; background: transparent;"> | ||
| - | <span style="color:blue"> '''Project''' </span | + | <span style="color:blue"> '''Project''' </span> |
'''Introduction''' | '''Introduction''' | ||
| - | + | [[Team:SupBiotech-Paris/Current therapies|Current therapies]] | |
| - | + | [[Team:SupBiotech-Paris/Gene therapies|Gene therapies]] | |
'''1st observation''' | '''1st observation''' | ||
| - | + | [[Team:SupBiotech-Paris/Introduction1|Introduction]] | |
| - | + | [[Team:SupBiotech-Paris/Concept1|Concept]] | |
| - | + | [[Team:SupBiotech-Paris/Conclusion1|Conclusion]] | |
'''2nd observation''' | '''2nd observation''' | ||
| - | + | [[Team:SupBiotech-Paris/Introduction2|Introduction]] | |
| - | + | [[Team:SupBiotech-Paris/Concept2|Concept]] | |
| - | + | [[Team:SupBiotech-Paris/Conclusion2|Conclusion]] | |
'''Implementation''' | '''Implementation''' | ||
| - | + | [[Team:SupBiotech-Paris/Tissue targeting|Tissue targeting]] | |
| - | + | [[Team:SupBiotech-Paris/Cell targeting|Cell targeting]] | |
| - | + | [[Team:SupBiotech-Paris/Modification|Protein modification]] | |
| - | + | [[Team:SupBiotech-Paris/Conclusion3|Conclusion]] | |
<span style="color:blue"> '''Ressources'''</span> | <span style="color:blue"> '''Ressources'''</span> | ||
| - | + | [[Team:SupBiotech-Paris/Biobricks|Biobricks]] | |
| - | + | [[Team:SupBiotech-Paris/Material & Method|Material & Method]] | |
| - | + | [[Team:SupBiotech-Paris/Bibliography|Bibliography]] | |
<span style="color:blue">'''Ethic & Safety'''</span> | <span style="color:blue">'''Ethic & Safety'''</span> | ||
| - | + | [[Team:SupBiotech-Paris/Synthetic Biology|Synthetic Biology]] | |
| - | + | [[Team:SupBiotech-Paris/Our project|Our project]] | |
| - | + | [[Team:SupBiotech-Paris/Safety|Safety]] | |
| Line 93: | Line 93: | ||
<html> | <html> | ||
<div style="margin-left: -5px;"> | <div style="margin-left: -5px;"> | ||
| - | < | + | <z href="http://www3.clustrmaps.com/counter/maps.php?url=https://2009.igem.org/Team:SupBiotech-Paris" id="clustrMapsLink"><img src="http://www3.clustrmaps.com/counter/index2.php?url=https://2009.igem.org/Team:SupBiotech-Paris" style="border:0px;" alt="Locations of visitors to this page" title="Locations of visitors to this page" id="clustrMapsImg" onerror="this.onerror=null; this.src='http://www2.clustrmaps.com/images/clustrmaps-back-soon.jpg'; document.getElementById('clustrMapsLink').href='http://www2.clustrmaps.com';" /> |
| - | </ | + | </z> |
</div> | </div> | ||
</html> | </html> | ||
Revision as of 19:09, 29 August 2009
Project Introduction Current therapies Gene therapies 1st observation Introduction Concept Conclusion 2nd observation Introduction Concept Conclusion Implementation Tissue targeting Cell targeting Protein modification Conclusion
Ressources
Biobricks
Material & Method
Bibliography
Ethic & Safety
Synthetic Biology
Our project
Safety
|
|
